Drs, Califf and Shuren believe better postmarket surveillance of medical devices stems from harnessing information from device registries, EHRs and claims data.
The FDA’s Sentinel Initiative collects claims data on the clinical outcomes of more than 100 million individuals. Drs. Califf and Shuren call for unique device identifiers to be incorporated into this database to help monitor long-term outcomes of medical devices.
The call to improve the national evaluation system for health technology falls in line with the FDA’s goal to better identify problematic devices, release data on device performance in clinical practice, and efficiently create data to support premarket clearance or approval of new devices or indications.
More articles on supply chain:
GAO: Fewer new drug shortages, while ongoing shortages remain steady
Newly approved heart stent implanted into first patient
2 new devices may stop choking when the Heimlich fails
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
